Michael Mark Millenson

9.3k citations
78 papers · 7.8k · 3 hit papers · h-index 32

Impact in

Papers in

Michael Mark Millenson

76 papers receiving 7.6k citations

Michael Mark Millenson's Hit Papers

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study 2016 · 879 citations
8790+4+8Years since publication1k2k3k

Peers

Michael Mark Millenson
Comparison fields: 5 of 96
  • Internal Medicine 553
  • Pathology and Forensic Medicine 2.5k
  • Oncology 2.4k
  • Hematology 1.2k
  • Genetics 218
Replace Matthew Alexander Lunning with:
Matthew Alexander Lunning United States
Rubén Niesvizky United States
Enrico Maria Pogliani Italy
Arthur T. Skarin United States
Ashraf Z. Badros United States
Susan Michelle Geyer United States
Lionel Karlin France
Stefano Luminari Italy
David H. Irwin United States
Anna Marina Liberati Italy
Michael Mark Millenson relative to Matthew Alexander Lunning United States Matthew Alexander Lunning's profile →
Citations per field
00.5×2×4×6×8×9.4×
Matthew Alexander Lunning · 1×
Citations per year

Countries citing papers authored by Michael Mark Millenson

Since Specialization
Citations

This map shows the geographic impact of Michael Mark Millenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mark Millenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mark Millenson more than expected).

Fields of papers citing papers by Michael Mark Millenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Mark Millenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mark Millenson. The network helps show where Michael Mark Millenson may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Mark Millenson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Mark Millenson Line = papers co-authored together Michael Mark Millenson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#Work
1
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Hit paper breakdown →
20143032
2
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
Hit paper breakdown →
2016879
3
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Hit paper breakdown →
2013729
4 2012295
5 2012260
6 2011239
7 2018187
8 2015184
9 2012180
10 2011168
11 2013158
12 2014105
13 201279
14 201377
15 201175
16 200872
17 201161
18 201361
19 201258
20 201356

About Michael Mark Millenson

Michael Mark Millenson is a scholar working on Pathology and Forensic Medicine, Hematology, Pulmonary and Respiratory Medicine, Internal Medicine and Genetics, having authored 78 papers that have together received 7.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (36 papers), Lung Cancer Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (8 papers), Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Erythropoietin and Anemia Treatment (3 papers). The work is most often cited by research in Internal Medicine (553 citations), Pathology and Forensic Medicine (2.5k citations), Oncology (2.4k citations), Hematology (1.2k citations) and Genetics (218 citations). Michael Mark Millenson has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Scott J. Rodig, Philippe A. Armand, Ahmad Sami Halwani, John M. Timmerman, Margaret Ann Shipp, Martin E Gutierrez, Ivan Borrello, Stephen Schuster, Gordon James Freeman and Azra Hadi Ligon. Their work appears in journals such as Blood, Journal of the National Comprehensive Cancer Network, Cancer, Journal of Thoracic Oncology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact